Press Releases

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- The many voices of patients with IgA nephropathy, a chronic kidney disease, will come together on Monday, August 19, during an

NORTH CHICAGO, Ill., Aug. 16, 2019 /PRNewswire/ -- AbbVie (NYSE: ABBV), a research-based global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved RINVOQ™ (upadacitinib), a 15 mg, once-daily oral Janus kinase (JAK) inhibitor, for the treatment of adults with moderately to severely active rheumat

TROY, Mich., Aug. 16, 2019 /PRNewswire/ -- Beaumont Hospital, Troy has once again achieved the highest hono

KANSAS CITY, Mo., Aug. 16, 2019 /PRNewswire/ -- Sam Cullan, M.D., J.D. of Cullan & Cullan has been named to Best Lawyers for 2020 in Medical Malpractice Law – Plaintiffs and Personal Injury Litigation – Plaintiffs. The selection marks the fifth time he has been officially recognized by Best Lawyers in America. From 2016 to 2019, he was also given th

NEW YORK, Aug. 16, 2019 /PRNewswire/ -- The brain has a knack for safekeeping our most treasured memories, from a first kiss to a child's birth. In a new study in mouse cells, Columbia neuroscientists have mapped some of the molecular machinery that helps the brain maintain these kinds of long-term memories. By observing the activit

CLEARWATER, Fla., Aug. 16, 2019 /PRNewswire/ -- In the US, up to 38 million people experience migraine, with some estimates suggesting that this number may be even higher, impacting as many as 50 million or more.

SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved an expanded indication for several transcatheter heart valves to include patients with severe aortic valve stenosis (a narrowing of the heart's aortic valve that restricts blood flow to aorta, the body's main artery) who are at low risk for death or major complica

IRVINE, Calif., Aug. 16, 2019 /PRNewswire/ -- Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today announced U.S. Food and Drug Administration (FDA) approval to expand use of the Edwards SAPIEN 3 and SAPIEN 3 Ultra transcatheter heart valve systems to the treat

WARSAW, Ind., Aug. 16, 2019 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, today announced U.S. Food and Drug Administration approval for The Tether™ for treatment of scoliosis, providing a fusion-less alternative for young patients requiring surgery.

SILVER SPRING, Md., Aug. 16, 2019 /PRNewswire/ -- The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic scoliosis, that has not responded to conservative treatment options, such as external bracing.  The device, called T